Stockreport

Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results

Panbela Therapeutics, Inc.  (PBLA) 
PDF MINNEAPOLIS, March 26, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment [Read more]